MAVENCLAD and Rebif are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.
Investigational agents and investigational indications for marketed products are under clinical investigation and have not been proven to be safe and effective. There is no guarantee any product will be approved in the sought-after indication. See the full EMD Serono pipeline on our corporate website.
DISEASE STATE EDUCATION
Additional Neurology Resources